{
    "eu_accel_assess_g": "Not available at time of release",
    "eu_od_number": "__SCRAPER_NOT_FOUND__",
    "active_substance": "pemetrexed",
    "eu_aut_status": [
        {
            "value": "ACTIVE",
            "date": "2023-01-09"
        }
    ],
    "eu_brand_name_current": [
        {
            "value": "Alimta",
            "date": "2023-01-09"
        }
    ],
    "assess_time_days_total": 309,
    "ema_od_number": "__SCRAPER_NOT_FOUND__",
    "eu_brand_name_initial": {
        "value": "Alimta",
        "date": "2023-01-09"
    },
    "assess_time_days_active": "Not found",
    "eu_od_con": "__SCRAPER_NOT_FOUND__",
    "ema_number": "EMEA/H/C/564",
    "atc_code": "L01BA04",
    "eu_nas": "Not available at time of release",
    "ema_number_id": "564",
    "assess_time_days_cstop": "Not found",
    "eu_od_date": "Date is left blank in source",
    "ema_procedure_start_initial": "2003-08-18",
    "chmp_opinion_date": "2004-06-22",
    "ema_number_certainty": "0.9148936170212766",
    "ec_decision_time_days": 6775,
    "eu_od_pnumber": "__SCRAPER_NOT_FOUND__",
    "eu_aut_date": "2004-09-20",
    "ema_number_check": true,
    "eu_aut_type_initial": {
        "value": "Not available at time of release",
        "date": "2023-01-09"
    },
    "eu_mah_current": [
        {
            "value": "Eli Lilly Nederland B.V.",
            "date": "2023-01-09"
        }
    ],
    "ema_reexamination": "False",
    "eu_od_sponsor": [
        {
            "value": "__SCRAPER_NOT_FOUND__",
            "date": "2023-01-09"
        }
    ],
    "eu_aut_type_current": [
        {
            "value": "standard",
            "date": "2023-01-09"
        }
    ],
    "eu_mah_initial": {
        "value": "Eli Lilly Nederland B.V.",
        "date": "2023-01-09"
    },
    "eu_orphan_con_current": [
        {
            "value": "__SCRAPER_NOT_FOUND__",
            "date": "2023-01-09"
        }
    ],
    "eu_od_comp_date": "Date is left blank in source",
    "eu_pnumber": "EU/1/04/290",
    "eu_prime_initial": {
        "value": "Not available at time of release",
        "date": "2023-01-09"
    },
    "eu_legal_basis": [
        "__SCRAPER_NOT_FOUND__"
    ],
    "eu_referral": "False",
    "eu_indication_initial": {
        "value": "alimta in combination with cisplatin is indicated for the treatment of chemotherapy na\u00efve patients with unresectable malignant pleural mesothelioma.\n\n alimta is indicated as monotherapy for the treatment of patients with locally advanced or metastatic \n non-small cell lung cancer after prior chemotherapy.\n",
        "date": "2023-01-09"
    },
    "aut_url": "https://ec.europa.eu/health/documents/community-register/2004/200409208268/dec_8268_en.pdf",
    "eu_od_initial": {
        "value": "__SCRAPER_NOT_FOUND__",
        "date": "2023-01-09"
    },
    "eu_suspension": "False",
    "ema_omar_condition": "__SCRAPER_NOT_FOUND__",
    "smpc_url": "https://ec.europa.eu/health/documents/community-register/2004/200409208268/anx_8268_en.pdf",
    "ema_rapp": "dr eric abadie",
    "omar_url": "404_url_not_found",
    "epar_url": "https://www.ema.europa.eu/documents/procedural-steps/alimta-epar-procedural-steps-taken-authorisation_en.pdf",
    "eu_procedures_todo": [
        {
            "eu_referral": false,
            "eu_suspension": false
        }
    ],
    "eu_atmp": "Not available at time of release",
    "ema_corapp": "prof tilman ott",
    "odwar_url": "404_url_not_found",
    "orphan_status": "h",
    "eu_med_type": "small molecule"
}